Key Highlights

● United States Antimony shares have fallen sharply, most recently closing at $5.26, down 8.20%, after Q2 2026 Revenue fell about 25% year over year to $7.9 million and the company swung to an operating loss of roughly $7 million.

● Management slashed full-year 2026 revenue guidance from roughly $125 million to a range of $65 million to $75 million, citing collapsing antimony prices and delivery and contract-timing delays.

● Antimony spot prices fell roughly 50% or more year over year, trading around $10 to $11 per pound during the quarter versus the $28 per pound assumption behind the original guidance.

● H.C. Wainwright cut its price target on the stock to $9.25 from $11.75 following the report, reflecting a broader reassessment of near-term Earnings power tied to the commodity's price collapse.

United States Antimony (NYSE American:UAMY) appears among the notable decliners on a recent snapshot of the biggest U.S. stock losers, and in this case the catalyst is well documented. The company reported disappointing second-quarter 2026 results in mid-August, paired with a dramatic reduction in its full-year revenue outlook, and the shares sold off sharply. The move stands in contrast to the enthusiasm that had lifted antimony-linked equities over the prior year, when Supply concerns and the critical-minerals policy theme drew a wave of speculative interest. The recent decline reflects that theme colliding with weak Commodity pricing and a company-specific shortfall.

What happened

Around 11--13 August 2026, U.S. Antimony released second-quarter results that badly missed expectations. Revenue fell roughly 25% year over year to about $7.9 million, well below analyst estimates that had been positioned far higher. The company swung to an operating loss of roughly $7 million versus a near-breakeven result a year earlier. Reported Net Income was only marginally positive at about $0.1 million, and the top-line figure came in dramatically short of consensus.

The larger shock was guidance. Management slashed full-year 2026 revenue guidance from roughly $125 million to a range of about $65 million to $75 million, a cut of nearly half against the prior target, and well below where Wall Street had been modeling. The company attributed the reduction to collapsing antimony prices, timing delays in antimony metal ingot deliveries, and shifts in the scheduling of government-related contracts. The stock fell more than 20% in the immediate aftermath, with one session dropping roughly 23%, and the weakness carried through the following week, the context in which the shares still register as a notable decliner on the 21 August snapshot.

The commodity is the core problem

The heart of the story is the antimony price itself. When U.S. Antimony issued its original guidance, that outlook assumed a selling price near $28 per pound. During the second quarter, spot prices for antimony fell dramatically, down roughly 50% or more year over year, with references to prices in the range of roughly $10 to $11 per pound in the quarter. Because the company's revenue model is highly sensitive to the realized selling price of the metal, a decline of that magnitude flows almost directly into both revenue and margins. A guidance framework built around $28 antimony simply does not hold when the metal trades at a fraction of that level.

That dynamic is a reminder of what the antimony trade always was: a leveraged bet on a thinly traded strategic metal whose price had spiked on supply-security fears, particularly around Chinese export controls and Western efforts to build domestic critical-minerals capacity. Antimony is used in flame retardants, lead-acid batteries, and a range of defense applications, and the scramble to secure non-Chinese supply had made producers with U.S. processing capacity a focal point for the reshoring narrative. When the price runs, small producers like U.S. Antimony can see outsized revenue and sentiment gains, and their equities tend to trade at rich multiples of trailing sales; when it retreats, the same Leverage works in reverse, and those multiples compress just as quickly.

The analyst response

The reaction extended beyond the tape. H.C. Wainwright reduced its price target on the stock, cutting it from $11.75 to $9.25 in the wake of the report. A lowered target from a covering firm reinforced the market's reassessment of near-term earnings power now that the pricing and guidance picture had changed, and it signaled that even analysts inclined toward the long-term critical-minerals thesis were resetting expectations for the current year. Beyond that specific action, the broader message from the quarter was that the company's realized results are far more exposed to volatile spot prices than the prior guidance had implied.

Why investors are concerned

Several threads run together. First, the guidance cut was severe and abrupt, undermining confidence in management's visibility on pricing, delivery timing, and contract scheduling. Second, the swing to an operating loss shows how quickly profitability can evaporate when the underlying commodity weakens, even for a producer positioned in a strategically important supply chain. Third, the delivery and contract-timing delays introduce uncertainty about whether the reduced guidance captures the full extent of the disruption or whether further slippage is possible. And fourth, the episode challenges the narrative that critical-minerals Demand and Western reshoring would provide a durable floor under prices and volumes, at least on the timeline the market had been pricing in.

It is worth distinguishing confirmed facts from interpretation. What is confirmed is the revenue shortfall, the operating loss, the roughly halved full-year guidance, the collapse in antimony spot prices relative to the guidance assumption, and the analyst target reduction. Whether this marks a broader, lasting cooling of the entire critical-minerals trade, as opposed to a sharp but potentially temporary pricing correction, is a matter of interpretation that the coming quarters will settle.

What to watch next

The single most important variable is the antimony price and whether it stabilizes, recovers, or continues to slide. Because the company's Economics track the metal so closely, any move in spot pricing will feed quickly into revenue and margins. Investors will also watch execution on the delayed metal ingot deliveries and the rescheduled government-related contracts, since resolving those timing issues could recover some of the lost revenue within the fiscal year. Progress on the company's broader critical-minerals expansion efforts, the strategic rationale that attracted investors during the run-up, remains relevant, but the market is likely to demand tangible delivery and revenue rather than announcements. Any updated guidance, additional analyst actions, or evidence that pricing has found a floor would be the clearest signposts for whether the sell-off has run its course or has further to go.